ARCT Arcturus Therapeutics Holdings

$14.73▲ +5.36% Healthcare Other
After hours $14.47▼ -1.77% Sep 11, 7:45 PM ET
Volume 496.6K Avg Volume (10D) 1.11M
Key Metrics & Fundamentals
Market Cap
$418.67M
P/E Ratio
–
Div Yield
–%
52W Range
5.50 - 24.17
% vs 50 MA
56.70%
% vs 200 MA
85.75%
RSI-14
62.1
MACD Histogram
-0.2600
Beta (1Y vs SPY)
1.95
Free Cash Flow
-$19.91M
Gross Rev
$880,000
Gross Profit
$880,000
EBITDA
-$24.84M
COGS
–
Operating Exp
$26.43M
Operating Income
-$25.55M
EBIT
-$25.55M
Pretax Income
-$23.79M
Net Income
-$23.79M
EPS (Diluted)
-0.84
Price & Volume History
Loading chart…
Recent News
Arcturus Therapeutics to Participate in Upcoming Investor Conferences
Business Wire · Aug 31, 2026 8:01 PM
Arcturus Therapeutics (ARCT) Just Flashed Golden Cross Signal: Do You Buy?
Zacks · Aug 27, 2026 1:55 PM
Can mRNA Cure Cancer? Inside the Pipeline Risks for Biotech’s Biggest Players
Barrons.com · Aug 21, 2026 6:54 PM
Moderna And Merck's Cancer Vaccine: Are Investors Putting The Cart Before The Horse?
Investor's Business Daily · Aug 20, 2026 8:07 PM
Arcturus Therapeutics Eyes Phase III CF Call, OTC Data as Vaccine Funds Pipeline
MarketBeat · Aug 12, 2026 1:04 AM
Arcturus Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 6, 2026 10:04 PM
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 6, 2026 9:20 PM
Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress
Business Wire · Aug 6, 2026 8:01 PM
Exelixis (EXEL) Tops Q2 Earnings Estimates
Zacks · Aug 5, 2026 10:10 PM
Earnings To Watch: Arcturus Therapeutics Holdings Inc (ARCT) Q2 2026 -- GF Value Sees 44% Downside
GuruFocus.com · Aug 5, 2026 1:43 PM
Financial Overview - Income Statement Quarterly

See ARCT's money flow as a full page

Social Sentiment
Avg -0.60 · 1 posts
ARCT: Can someone explain this please?
r/stocks · Jun 9, 2024
The post expresses significant skepticism and suspicion about the stock's volatility and potential for manipulation.
negative -0.60
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙